(ROC-MS) RituximabOCrelizumab - -

Lisa G Schoof1, Brit Ellen Rød2, Sahla El Mahdaoui3

  • 1MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC location VUmc, Amsterdam, the Netherlands.

概括

利图西马布 (RTX) 和奥克雷利祖马布 (OCR) 是多发性硬化症 (MS) 的抗CD20疗法. 一项对四项试验的新元分析将在RRMS患者中比较它们的疗效和安全性,为治疗决策提供更高质量的证据.